ASCO 2024 - Dr. Nagi S. El Saghir on New Advances in Sequencing CDK4/6 Inhibitors with Endocrine Therapy in Advanced Breast Cancer

Join Dr. Nagi S. El Saghir as he discusses new studies presented at ASCO 2024. He highlights recent studies on the sequencing of CDK4/6 inhibitors and endocrine therapy in patients with advanced breast cancer.